MECHANISM OF ACTION
The Meno-Pause blend is a proprietary (not publicly disclosed) combination of peptides designed to address the multiple ways menopause affects the body at once. Based on the known components, it likely includes: a peptide to support the hormonal signalling system (the brain-pituitary-ovary communication chain) that becomes disrupted during menopause; a peptide to support mood, calm, and mental clarity during the transition; and a repair-focused peptide for the physical changes like joint aches and tissue changes. Rather than replacing hormones with synthetic oestrogen, the approach tries to use the body's own peptide signalling systems to support balance during the transition. The exact formula and ratios are proprietary to the Peptide Pen brand.
RESEARCH APPLICATIONS
- Perimenopausal and menopausal symptom research
- HPG axis support (GnRH/LH pulsatility)
- Mood and anxiety modulation in hormonal transition
- Anti-ageing and recovery support for post-menopausal physiology
- Female HPG axis modulation in preclinical models
RESEARCH HIGHLIGHTS
Peptide Approach to Hormonal Transition
Kisspeptin, Selank, and recovery peptide components each have independent research support for their target axes - the combination addresses multiple menopausal symptom pathways simultaneously.
Ref: See individual compound pages for supporting research
RESEARCH PROTOCOL NOTES
Chemical Identity
Storage & Stability
2–8°C. Follow standard peptide storage - keep cold, protect from light, use reconstituted solution within 21 days.
Regulatory Status
Research compound. No regulatory approval. Not WADA prohibited. SA: unscheduled research compound.